Windlas Biotech Ltd. benchmarking: Performance to industry peers

Financial

	Windlas Biotech	Amrutanjan Healthcar	Kwality Pharma
Operational Metrics
Financials
5 yr Average ROE	10.64 %	14.67 %	25.27 %
5yr average Equity Multiplier	1.39	1.41	1.96
5yr Average Asset Turnover Ratio	1.07	1.22	1.05
5yr Avg Net Profit Margin	7.49 %	8.57 %	11.66 %
Price to Book	3.02	4.58	6.0
P/E	24.13	29.31	30.8
5yr Avg Cash Conversion Cycle	-12.87 Days	21.59 Days	55.02 Days
Inventory Days	39.91 Days	23.18 Days	67.04 Days
Days Receivable	72.81 Days	51.48 Days	132.46 Days
Days Payable	93.99 Days	49.13 Days	126.93 Days
5yr Average Interest Coverage Ratio	42.87	27.21	16.13
5yr Avg ROCE	16.39 %	24.07 %	34.73 %
5yr Avg Operating Profit Margin	12.11 %	14.15 %	23.23 %
5 yr average Debt to Equity	0.05	0.12	0.46
5yr CAGR Net Profit	30.97 %	16.38 %	21.34 %
5yr Average Return on Assets	7.71 %	10.59 %	12.96 %
Shareholdings
Promoter Holding	61.9 %	46.52 %	54.87 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.48 %	-3.52 %	0.13 %
Change in Mutual Fund Holding (3 Yrs)	-3.56 %	0.1 %	0.0

	Windlas Biotech	Amrutanjan Healthcar	Kwality Pharma
Product Wise Break-Up	Product Wise Break-Up CDMO 71.67 Trade Generics & OTC 22.75 Exports 5.58 Women Hygiene 0 Beverages 0 OTC Products 0	Product Wise Break-Up OTC 71.29 Women Hygiene 26.01 Beverages 2.19 CDMO 0 Exports 0 Trade Generics & OTC 0 Others 0.51	-
Location Wise Break-Up	Location Wise Break-Up India 95.68 Rest of the World 0 North India 0 East India 0 West India 0 South India 0 India 0 Others 4.32	Location Wise Break-Up Rest of the World 0 North India 4.0 West India 12.0 East India 26.0 South India 58.0 India 0	Location Wise Break-Up Rest of the World 0 North India 0 West India 0 East India 0 South India 0 India 47.21 Others 52.79
Acute vs Chronic	Acute vs Chronic Chronic & Sub-Chronic 59.0 Acute 41.0	-	-
Segment Wise Break-Up	Segment Wise Break-Up Pharmaceutical 100.0	-	-